Date post: | 22-Jul-2016 |
Category: |
Documents |
Upload: | invest-in-wallonia |
View: | 216 times |
Download: | 0 times |
BioWin is the regional reference player in the fields of health biotechnology and medical technologies.
The cluster gathers all the companies, universities and research centers involved in innovative R&D projects
supporting the development and the delivering of new
products and services to the global market.
BioWin’s strategic activities:• Regional&Internationalinnovative R&D projects
• International networking & partnering
(in Europe, China and the US)
• Trainingprogramsspecifictothebioindustry
• Supporttothecreationoftechnologicalplatforms
BioWin’s members are active in the followingkeytechnologicalareas:
• Biopharmacy
• Celltherapy®enerativemedicine
• Immunology
• Diagnostics(in vitro & in vivo)
• Radiationapplicationsinhealthcare
• Instruments&medicaldevices
• Biotechproducts&services
www.biowin.org
Our members are active in the following key technological areas:
• Biopharmacy
• Cell therapy & Regenerative medicine
• Immunology
• Diagnostics (in vitro & in vivo)
• Radiation applications in healthcare
• Instruments & medical devices
• Biotech products and services
© M
asTH
erCe
ll 2
01
3
BioWin, your gateway to health biotech and medtech excellence
WWW.BIOWIN.ORG
CONTACT BIOWIN NOW TO FIND YOUR SCIENCE AND/OR BUSINESS PARTNER IN WALLONIA!
BIOW-14-14193-Annonce Presse-cr-080914-bat.indd 1 8/09/14 16:12
The place to innovate in life sciences
InvestinWallonia
Wallonia Export - Investment Agency Forexport:[email protected]
Forforeigninvestment:[email protected]
(T) +32 81 33 28 50
www.investinwallonia.be AW
EX
10
/20
14
Wallonia Export - Investment Agency, yourgatewaytoWallonia - Europe
WalloniaExport-InvestmentAgencyisyourone-stopshop
andpartnerstartingfromtheveryonsetofyourstudies
andEuropeandevelopment.Withus,you’llfindscientific,
fiscal and business expertise to prepare, launch or develop
youractivities.Withus,you’llfindthekeythatopensthe
door to academic, scientific and industrial networks.
BiowinjoinsWalloniaExport-InvestmentAgencytocreate
ateamofspecialistsdedicatedtoyourproject.
Contact us!London
Amsterdam
FrankfurtParis
BrusselsWallonia
R&Dincentives
Keyinformation(Wallonia, sectors,...)
Talents recruitment & training
Businessplan
Site selection
Multilingualsector experts
Tax & legalassistance
Wallonia - Belgium The place to innovate in life sciences
Wallonia, the southernmost region of Belgium, has
developed itself into a center of life science companies
through major investments in R&D. The ongoing efforts
to improve the business environment in the region have
allowed companies to improve their competitiveness
through lower costs and easier access to facilities and
qualified workforce. Furthermore, companies have been
largelybenefiting from the financial support offered by Wallonia in the form of R&D subsidies, advances and tax reduction for research.
LondonAmsterdam
FrankfurtParis
BrusselsWallonia
7 key reasons tolocateinWallonia:
• Unique location attheveryheartofEurope• European leader in clinical research• Favorable tax environment and R&D incentives • Biotechhub connected with first-class clusters and organisations worldwide• Top capacities to develop and deliver innovative
products&servicesfrombenchtomarketinkeyareas
• Worldwide leaders trust us: GSK, IBA, Zoetis,... • Biolog Europe,afacilitatorinSupplyChain Management (SCM)
We are now at a stage where our production capacity
must increase to INDUSTRIAL SCALE and we look
forward to moving all our operations to these cutting-edge,
high-techpremises :theWalloonCellTherapyPlatformat
the new Biopark Charleroi Brussels South
Enrico BASTIANELLICEO of Bone Therapeutics
“
”
Wallonia is the excellent place for investments in the Life
Sciences sector because there is a dense network of biotech companies and universities with activities in life sciences.
Moreover, the Walloon Government has made a strategic
decision to support the implementation and development
of companies with tax incentives and direct financial
support through the Biowin cluster to collaborative research
projectsbetweenIndustryandAcademia
Takamune YASUDACOO, Eurogentec (KANEKA Group)
“
”
We are delighted to PARTICIPATE in the Walloon
Cell Therapy Platform project, that has been made
possibleby theWalloonRegion,whichhas supportedus
from the outset. This partnership allows us to pool resources
and increase efficiencywhilerespectingeachcompany’s
know-howandintellectualproperty
Eric HALIOUA CEOofPrometheraBiosciences
“
”
The four large universities are playing a part in the
industrialredeployment.Thevice-chancellorsnowconsider
they have a part to play in economic development.
Consequently, the universities are closer to market requirements and current industrial developments.Theyseechangepositively,andliketheSMEs,wanttocontribute
to it. The success of centres of competitiveness will not be
abletomaterializewithoutaclosesynergybetweenallthe
players
Jean STÉPHENNEFormer CEO and Chairman of GSK
“
”
Wallonia is ideally located for shippingbyroadto our two major markets, FranceandGermany,and isclose to
the freight airports at Liege and Brussels. The region has
the support of the public authorities and all of the workforce
weneedisavailable.Ourteamswork7daysaweek,which
enablesustohandleanaverageof4,000ordersaday
Jean-Michel COLNOT Operations Director, Johnson & Johnson
“
”
Wallonia, whatyoushouldknow & what theplayersaresaying
Choosing La Louvière and Wallonia in general for setting
upournewdistributioncentrewasmadeeasybyitslocationat
theeveryheartofseveralmajormarkets,andbyafavourable
network of road, railway and airport transport systems.
Moreover, Belgian scientific know-how in thepharmaceutical
sector, in addition to a “highly competitive tax climate
were also decisive factors
Dirk COLLIER CorporatesecretaryofJanssenPharmaceutica
(J&J Group)
“
”
€